The Innovator U.S. Equity Power Buffer ETF – November, trading under the ticker PNOV, is an exchange-traded fund that offers a distinctive twist on broad U.S. stock market exposure. Instead of simply tracking an index, it aims to provide investors with a "defined outcome" — a predetermined level of downside protection paired with a cap on upside gains over a fixed, roughly one-year period. This structure has made Innovator's "buffer" ETFs popular among investors who want equity participation while seeking to reduce the anxiety of sharp market drawdowns.
PNOV belongs to Innovator's lineup of defined-outcome ETFs, a category sometimes called "buffer" or "outcome" funds. An ETF is a pooled investment vehicle that trades on an exchange like a stock, and NAV (net asset value) is the per-share value of the fund's underlying assets. The fund was launched on October 31, 2019, and is issued by Innovator Capital Management, LLC, with Milliman Financial Risk Management LLC serving as co-manager. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the category.
The fund's investment strategy centers on FLexible EXchange (FLEX) options — customizable, exchange-listed options contracts — that reference the performance of the SPY, a widely used vehicle that tracks the S&P 500 Index. The fund commits at least 80% of its net assets to these options and to collateral, rather than purchasing the underlying stocks of the S&P 500 directly.
Each year, on the first business day of November, PNOV establishes a new outcome period. During that period, the fund seeks to deliver the price return of the S&P 500 up to a predetermined cap, while buffering investors against the first 15% of losses in the reference asset. Because the 0.79% management fee is deducted from daily net assets, the net buffer after fees is approximately 14.21%. Investors who hold the fund through an entire outcome period receive the stated outcome; those who buy or sell mid-period may experience different results.
Because PNOV uses a derivatives-based structure, its portfolio holdings look very different from a conventional index fund. Instead of hundreds of individual company shares, the fund's largest positions consist of FLEX options on the SPDR S&P 500 ETF Trust, which have typically represented nearly all of the fund's net assets, alongside cash or short-term collateral. The underlying reference asset spans the diversified sectors of the S&P 500, with technology, financial services, and healthcare among the most heavily weighted areas, reflecting the composition of the broader index.
The fund's expense ratio of 0.79% is higher than a plain-vanilla index ETF, reflecting the specialized options strategy and the defined-outcome structure. PNOV is classified as a non-diversified fund under the Investment Company Act of 1940, meaning it can concentrate its holdings to a greater degree than diversified funds, though its core exposure remains the S&P 500.
PNOV attracts attention primarily for its investment strategy of blending equity upside with a defined buffer against losses. For investors uncomfortable with the full volatility of the stock market, the fund offers a way to maintain sector exposure to large-cap U.S. equities while capping the downside over a known time horizon. The resetting outcome period also allows investors to potentially hold the fund continuously and "roll" into a new buffer and cap each November.
The fund's appeal is rooted in risk management rather than income or aggressive growth. It may suit investors with a moderate risk tolerance, those nearing a planned withdrawal or life event, or anyone seeking a more predictable return profile over a specific window. The cap-and-buffer design means investors knowingly trade away some upside in exchange for downside protection — a trade-off that defines the entire category.
Investors should understand several important limitations before buying PNOV. The cap limits total gains for each outcome period, meaning the fund can lag a soaring market. The buffer applies only to the first 15% of losses; declines beyond that threshold are borne by the investor. The stated outcome is generally available only to shareholders who hold the fund for the full outcome period, so intra-period purchases or sales can produce results that differ from the advertised buffer and cap.
Other considerations include the 0.79% expense ratio, which is higher than traditional index ETFs, and the fund's reliance on the liquidity and pricing of FLEX options. As a non-diversified fund, PNOV also carries concentration considerations, though its underlying reference is broad. Finally, the cap and buffer reset annually based on prevailing market conditions, so future periods may offer different terms than the current one.
In my own research, I often turn to Tickeron’s AI Screener to quickly compare defined-outcome ETFs like PNOV against peers using technical indicators, volatility metrics, and custom filters. It helps surface ideas that align with specific risk-management strategies without sifting through thousands of options manually. This kind of tool can be especially useful when evaluating how different buffer levels and caps stack up across the category.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
PNOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 37 cases where PNOV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 44 cases where PNOV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
Following a +1.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where PNOV advanced for three days, in 229 of 377 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Aroon Indicator entered an Uptrend today. In 321 of 493 cases where PNOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
The 10-day RSI Indicator for PNOV moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In 18 of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at 36%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PNOV as a result. In 41 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for PNOV turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 25 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 52%.
PNOV moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PNOV crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PNOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows